Search

… Thierry is originally from tiny Luxembourg. He moved to Freiburg in Southern Germany to study medicine and graduated in 2010. For his MD thesis, Thierry worked on the viral polymerase as a virulence factor for Influenza A Virus.  He completed his medical training in Internal Medicine and Infectious Diseases

… Job Title Administrative Assistant

At Memorial Sloan Kettering, our team of doctors & experts includes three pediatric neurologists and four pediatric oncologists who specialize in the care of children with brain tumors.

… Our Pediatric Brain Tumor Service works across disciplines to provide comprehensive care to children, adolescents, and young adults with brain or central nervous system tumors. We know you probably have a lot of questions about what to do now. Our neurosurgeons offer same-day phone consultations. Call

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.

… Wednesday, October 1, 2008 Summary Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008. Scott N. Keeney , a member of the Molecular Biology Program within

… Job Title Graduate Research Assistant Email [email protected]

… Job Title PhD Student Degree BS

Scientist - Induces Proximity Platform (IPP), Amgen

… Job Title Scientist - Induces Proximity Platform (IPP), Amgen During my undergraduate studies, I was working on understanding how tumor cells evade cell death, and I became really interested in the cell biology of tumor cells. I knew I wanted to pursue a scientific career, and a PhD was the next step

… Species:  Human Category:  Cancer Tissue of Origin:  Lung Cancer Type:  Lung Adenocarcinoma Description SK-LC-02 is a human lung cancer cell line. Source This cell line was established from a lung metastasis in a 65-year-old male with lung adenocarcinoma. Lead Researcher/Research Laboratory Lloyd J.

Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn - which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.

… Monday, September 13, 2010 Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center , will